Clinical Immunology Society
  • I Am CIS

  • Post a Job on the NEW CIS Job Board

    Read More

  • CIS 2019 Annual Meeting

    Read More

  • 2019 CIS Diagnostic School in PID

    Read More

  • Your CIS Membership can begin today

    Read More

  • We are dedicated to education, research and more

    Read More

Featured Resource

JoCI November Issue

The Journal of Clinical Immunology is a bimonthly international journal that helps researchers and academic clinicians keep current on investigative basic immunology and diseases related to the immune system. This well-established journal publishes articles on basic, translational, and clinical studies in all aspects of immunology, including animal models of human diseases.

 

Read More

Letter from the President

Dear Colleagues:

Summer is over, and everyone is back to the routine, with a new academic year, for many of our members. CIS has had a very busy and productive few months since our annual meeting in April 2018. We are immensely grateful to our members who have continued to work on many of our initiatives despite busy and over-committed schedules. The CIS Leadership met at the end of August for our annual Leadership Retreat, during which time a strategic plan was developed for the next five years (2018-2023). The Council decided to focus on 6 key initiatives – education, innovation, membership, communication, advocacy, and partnership, over the course of the next few years. The leadership also reaffirmed the primary values of the Society, and we created a new visual to summarize our mission statement...

 

Read More

Tales from the Listserv

In our opinion, by enabling us to consult and ask for previous experiences from our colleagues, the CIS PIDD-Listserv is an invaluable service to us all taking care of rare immunologic disorders. 

 

Read More

Pioneers in Clinical Immunology

Kate Sullivan, MD, PhDDr. Kate Sullivan

"A few gender-specific thoughts are in order given the mission of this group. I have many traditional female traits. I’m a builder of consensus, I lead by example, I try to build trust and forge community. But- niceness must not be mistaken for weakness. It is possible to be simultaneously fierce, supportive, and pleasant. Maybe that is not your personality. Great!  I don’t want you to be like me. I want you to be better and to succeed by being you."

 

Continue Reading

Current News

Please wait while we gather your results.

Hyper IgM Foundation Offers $25K in Seed Grant Funding

The Hyper IgM Foundation is proud to announce the availability of $25,000 in seed grant funding for researchers interested in the advancement of a cure for Hyper IgM Syndrome and primary immunodeficiency disorders. The intent of this funding is to accelerate scientific work focused on improving the treatment, quality of life, and long-term outlook for patients with Hyper IgM. Special consideration will be given to well-defined projects focused on gene therapy/editing for CD40 Ligand Deficiency as well as hematopoietic stem cell transplantation for CD40 Ligand Deficiency. During the 2019 calendar year, the Hyper IgM Foundation will be awarding one-time grants of up to $25,000 to worthy recipients. Grant applications for 2019 grants have a submission deadline of June 30th, 2019.

Learn More

IDF Grant Available

The IDF Research Grant Program is now accepting applications for 2019.

Learn More

NIH Clinical Trails in PIDs - Round Table Planned for 2020

The NIH, the National Institute of Allergy and Infectious Diseases (NIAID) and other participating Institutes, support several funding opportunities for clinical trials in broad scientific areas that represent the interests and competencies of investigators.

Learn More

CIS Case Conference Webinar Series

CIS is pleased to provide recordings of our webinar series of immune deficiency case presentations. Hosted by the ECI Committee, this interactive electronic format emphasizes discussion of interesting cases where we can all learn from each other. Registration is free and all are welcome!

 

Watch Now

 
Next Webinar: April 23, 2019

 

top